Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral anticoagulants (NOACs) that have been compared in clinical trials with existing anticoagulants (warfarin and enoxaparin) in several indications for the prevention and treatment of thrombotic events. All NOACs prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarah, Lessire, Anne-Sophie, Dincq, Jonathan, Douxfils, Bérangère, Devalet, Jean-Baptiste, Nicolas, Anne, Spinewine, Anne-Sophie, Larock, Jean-Michel, Dogné, Maximilien, Gourdin, François, Mullier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084591/
https://www.ncbi.nlm.nih.gov/pubmed/25032218
http://dx.doi.org/10.1155/2014/616405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084591/
https://www.ncbi.nlm.nih.gov/pubmed/25032218
http://dx.doi.org/10.1155/2014/616405

Ejemplares similares